Jonathan Alspaugh
Insider Reports History
- Location
- Austin, TX
- Signature
- /s/ Jonathan Alspaugh
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Jonathan Alspaugh:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | President and CFO | Employee Stock Option (right to buy) | 19,787,969 | 22 Jun 2023 | Direct |
Insider Reports Filed by Jonathan Alspaugh
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SYRE | Aeglea BioTherapeutics, Inc. | 22 Jun 2023 | 1 | $0 | 4 | President and CFO | 30 Jun 2023, 16:34 |
| SYRE | Aeglea BioTherapeutics, Inc. | 23 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 24 Feb 2023, 17:20 |
| SYRE | Aeglea BioTherapeutics, Inc. | 23 Aug 2022 | 1 | $0 | 4 | Chief Financial Officer | 25 Aug 2022, 19:34 |
| SYRE | Aeglea BioTherapeutics, Inc. | 11 Mar 2022 | 1 | +$156,000 | 4 | Chief Financial Officer | 15 Mar 2022, 18:30 |
| SYRE | Aeglea BioTherapeutics, Inc. | 17 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 22 Feb 2022, 15:50 |
| SYRE | Aeglea BioTherapeutics, Inc. | 09 Dec 2021 | 1 | +$186,000 | 4 | Chief Financial Officer | 13 Dec 2021, 19:37 |
| SYRE | Aeglea BioTherapeutics, Inc. | 16 Aug 2021 | 3 | +$262,660 | 4 | Chief Financial Officer | 18 Aug 2021, 17:21 |
| SYRE | Aeglea BioTherapeutics, Inc. | 06 Jul 2021 | 1 | $0 | 4 | Chief Financial Officer | 08 Jul 2021, 17:12 |
| SYRE | Aeglea BioTherapeutics, Inc. | 06 Jul 2021 | 0 | $0 | 3 | Chief Financial Officer | 08 Jul 2021, 17:10 |